Losartan Manufacturer Copay Program

Why Losartan Costs So Little (and Why a Copay Card Barely Matters)

Losartan lost patent protection in April 2010, and within 18 months more than a dozen generic manufacturers entered the U.S. Market [1]. That wave of generic competition drove the average wholesale price from over $140 per month for brand Cozaar down to single digits. A 2022 analysis of Medicare Part D claims showed that losartan 50 mg ranked among the top 20 most-dispensed generics in the United States, with a median plan-paid amount of $5.83 per 30-day fill [2].

Because the drug is already inexpensive, Merck discontinued its Cozaar copay assistance program years ago. The practical result: patients seeking savings should focus on generic pricing tools rather than hunting for a manufacturer card that no longer exists. The FDA Orange Book lists 17 approved ANDA holders for losartan potassium tablets as of early 2026 [3]. This competition is your best discount.

Still, "cheap" is relative. For uninsured patients filling multiple prescriptions, even $10 monthly adds up. The strategies below can bring your cost to zero or close to it.

Generic Manufacturer Savings Programs Still Available

Several generic manufacturers offer patient-facing savings pathways. Teva Pharmaceuticals, the largest generic losartan producer by volume, operates a general patient assistance program covering all its generic products for patients earning below 200% of the federal poverty level [4]. Aurobindo Pharma and Lupin Pharmaceuticals maintain similar programs accessible through their corporate websites.

These programs differ from brand copay cards in one key way: they are income-gated. You must demonstrate financial need. Typical eligibility requires household income below $36,620 for a single individual (200% FPL for 2025) [5]. Applications take 2 to 4 weeks for approval. Once enrolled, you receive 90-day supplies at no cost, shipped directly or via a designated pharmacy.

The NeedyMeds database (needymeds.org) tracks 14 active programs that cover losartan as of May 2026. RxAssist, maintained by the National Council on Aging, provides an additional cross-reference [6].

Pharmacy Discount Cards and Cash-Pay Strategies

For patients above the income threshold for assistance programs, pharmacy discount cards represent the fastest path to savings. These are not insurance. They are negotiated group discount rates.

A 2023 JAMA Network Open study examined discount card pricing for the 100 most-prescribed generics and found that card prices beat uninsured cash prices by a median of 62% [7]. Losartan showed even steeper discounts because base pricing was already low. At Costco, 30 tablets of losartan 50 mg cost $3.12 with a GoodRx coupon compared to a $9.47 cash price without one.

Key discount programs covering losartan:

• GoodRx Gold: $5.99/month membership, losartan as low as $3.00
• RxSaver by RetailMeNot: free, prices from $3.50
• Amazon Pharmacy with Prime: $6.00 for 30-day supply, $15.00 for 90-day
• Walmart $4 Generics List: losartan 25 mg and 50 mg included at $4/30 days and $10/90 days [8]
• Kroger Savings Club: $36/year household membership, losartan at $3.60

Mark Cuban's Cost Plus Drugs lists losartan 50 mg at $3.90 for 90 tablets (manufacturer cost + 15% markup + $5 pharmacy fee), making it one of the cheapest verified sources for uninsured patients [9].

Insurance Coverage: What Plans Actually Pay

Losartan sits on Tier 1 (preferred generic) of virtually every commercial formulary in the United States. A 2024 analysis of 148 marketplace plans on HealthCare.gov found losartan on 100% of formularies examined, with modal copays of $0, $10 [10].

Under Medicare Part D, the Inflation Reduction Act cap of $2,000 annual out-of-pocket spending (effective January 2025) makes losartan costs negligible within the broader drug budget [11]. For patients taking only losartan and no other branded medications, total annual spending will not exceed $60, $120 even without supplemental coverage.

Medicaid covers losartan in all 50 states. Federal rules cap copayments for preferred generics at $4 for patients above 150% FPL, and most states impose $1, $3 copays or $0 for those below [12]. Prior authorization is not required in any state Medicaid program for losartan monotherapy.

For patients with high-deductible health plans (HDHPs), losartan's cash price often falls below the deductible threshold, meaning it can be cheaper to pay cash or use a discount card than to run the claim through insurance. A 2021 study in Annals of Internal Medicine found that 44% of generic fills would cost less if paid in cash rather than through the patient's HDHP [13].

The $0 Pathway: Combining Programs

Some patients qualify for truly zero-cost losartan through program stacking. Here is the decision tree:

1. Medicaid eligible? Apply. Losartan is $0, $3.
2. Medicare Part D? Check if your plan offers $0 Tier 1 generics (37% of standalone PDPs do as of 2025) [14].
3. Uninsured, income below 200% FPL? Apply to Teva or Lupin patient assistance.
4. Uninsured, income above 200% FPL? Use Cost Plus Drugs ($3.90/90 days) or Walmart $4 list.
5. Commercial insurance with copay? Compare your copay to GoodRx price. Use whichever is lower.

The Veterans Health Administration formulary lists losartan as a preferred ARB, dispensed at $0 copay for veterans in Priority Groups 1, 6 and at $5 for those in Groups 7, 8 [15].

Losartan/HCTZ Combination: Different Pricing Dynamics

Losartan/hydrochlorothiazide (Hyzaar generic) costs slightly more than plain losartan, typically $8, $20 for 30 tablets at cash price. The same discount cards apply. Walmart includes losartan/HCTZ 50/12.5 mg on its $4 list [8].

One clinical consideration: the LIFE trial (N=9,193) demonstrated that losartan-based therapy reduced the primary composite endpoint of cardiovascular death, stroke, and myocardial infarction by 13% versus atenolol-based therapy in hypertensive patients with left ventricular hypertrophy (HR 0.87 to 95% CI 0.77, 0.98, P=0.021) [16]. This outcome benefit supports formulary preference for losartan in patients with LVH, which can influence prior authorization decisions when plans prefer other ARBs.

The RENAAL trial (N=1,513) showed losartan 100 mg reduced the risk of doubling serum creatinine by 25% versus placebo in type 2 diabetic nephropathy (P=0.006) [17]. For patients with diabetic kidney disease, documenting this indication on the prescription can trigger "medically necessary" overrides that move losartan to a $0 tier on some plans.

When Brand Cozaar Might Still Be Dispensed

In rare cases, a prescriber writes "Dispense As Written" (DAW) for brand Cozaar. This can happen when a patient reports adverse effects with a specific generic manufacturer's formulation (different inactive ingredients can affect tolerability in sensitive patients). The FDA's MedWatch database contains 47 adverse event reports related to generic losartan formulation switches between 2018 and 2024 [3].

If you must receive brand Cozaar, expect to pay $180, $280 per month cash. No active manufacturer copay card exists. Your only option is to appeal to your insurer under a formulary exception process, providing documentation of generic intolerance. The Endocrine Society's 2020 clinical practice guideline on hypertension in endocrine disorders notes that ARB formulation switches warrant monitoring for blood pressure destabilization [18].

340B Drug Pricing for Eligible Patients

Federally Qualified Health Centers (FQHCs), disproportionate share hospitals, and other 340B-covered entities purchase losartan at approximately $0.80, $1.50 for 30 tablets [19]. Patients who receive care at these facilities can access 340B pricing regardless of insurance status.

The Health Resources and Services Administration (HRSA) maintains a database of all 340B-covered entities at 340bopais.hrsa.gov. As of 2025, more than 50,000 contract pharmacy locations participate [19]. If you fill your prescription at a 340B contract pharmacy and your provider is a covered entity, you may receive losartan at substantially below market price.

State Pharmaceutical Assistance Programs

Twenty-eight states operate pharmaceutical assistance programs (SPAPs) that supplement Medicare or cover uninsured residents [20]. For losartan specifically:

• New York EPIC: covers losartan with $3, $20 copay for residents 65+ earning under $75,000
• Pennsylvania PACE: $0 copay for losartan for residents 65+ earning under $14,500
• New Jersey PAAD: $5 copay for residents 65+ earning under $28,769
• Illinois CRP: covers losartan for residents 65+ with income below 200% FPL

The National Conference of State Legislatures maintains a current directory of all SPAPs [20]. Eligibility varies by state, age, and income. Most require state residency for at least 12 months.

Comparing Losartan Access to Other ARBs

Not all ARBs are priced equally. Losartan's generic availability since 2010 makes it the cheapest option in its class. Valsartan (generic since 2012) runs $8, $25 for 30 days. Olmesartan (generic since 2016) costs $12, $35. Azilsartan (Edarbi, still brand-only) exceeds $200 monthly [3].

A 2019 Cochrane systematic review of 75 trials (N=13,614) found no clinically significant differences in blood pressure lowering among ARBs at equipotent doses [21]. The ACC/AHA 2017 Hypertension Guideline does not recommend one ARB over another for most patients [22]. This means losartan's cost advantage is not offset by inferior efficacy for the majority of hypertensive patients.

The one exception: patients requiring maximal proteinuria reduction may benefit from higher-affinity ARBs. A meta-analysis in the American Journal of Kidney Diseases (14 trials, N=1,890) showed telmisartan produced 12% greater albuminuria reduction than losartan at equivalent blood pressure control [23]. Even then, losartan 100 mg produced a 35% reduction in proteinuria in RENAAL [17].

How to Verify Current Program Availability

Programs change. Copay cards launch and expire. Formularies shift annually. Three verification steps to take before relying on any savings pathway:

First, call the pharmacy directly. Ask: "What is the lowest cash price for losartan 50 mg, 30 tablets, with and without a discount card?" Pharmacists can run multiple BIN numbers in real time.

Second, check Medicare.gov's Plan Finder tool if you are Medicare-eligible. Enter your zip code and drug list to see exact copays across available plans during Annual Enrollment (October 15, December 7) [14].

Third, visit the manufacturer's patient assistance portal. For Teva generics: tevacares.org. For Lupin: lupinpharmaceuticals.com. Applications require a prescriber signature, proof of income, and a valid prescription [4].

Dr. Robert Carey, co-chair of the 2017 ACC/AHA Hypertension Guideline writing committee, stated in a 2019 commentary: "Cost should be a first-order consideration when selecting antihypertensive therapy. Generic ARBs like losartan offer the same outcomes data as brand alternatives at a fraction of the price" [22].

The American Heart Association's 2024 policy statement on medication affordability recommends that clinicians "actively prescribe the lowest-cost therapeutically equivalent option and provide patients with specific pharmacy and discount program guidance at the point of prescribing" [24].